. A scale-up recombinant methi-HR gel-filtration chromatography. Unreacted rMET-oninase (rMETase) production protocol has been estabase was removed by DEAE Sepharose FF anion-ex-lished with high yield (60%), high purity (98%), high change chromatography. The resulting PEG-rMETase stability, and low endotoxin for preclinical and clinical subunit, from a PEG/rMETase ratio of 30/1 in the syn-studies targeting the methionine dependence of human thetic reaction, had a molecular mass of approxi-cancer (12). 
A tumor-selective target with high therapeutic potenrMETase from 10 to 40 were used for PEGylation of tial is the elevated minimum methionine dependence of rMETase. PEGylation reactions were run at 20ЊC for 30 most and possibly all types of tumor cells relative to to 60 min in reaction buffer (20 mM sodium phosphate normal cells (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . The L-methionine a-deamino-gbuffer, pH 8.3). The PEGylated molecules (PEG-rMET-mercaptomethane lyase (methioninase, METase) gene ase) were purified from unreacted PEG with Amicon from Pseudomonas putida has been previously cloned in 30 K centriprep concentrators or by Sephacryl S-300 Escherichia coli (12) (13) (14) . A scale-up recombinant methi-HR gel-filtration chromatography. Unreacted rMET-oninase (rMETase) production protocol has been estabase was removed by DEAE Sepharose FF anion-ex-lished with high yield (60%), high purity (98%), high change chromatography. The resulting PEG-rMETase stability, and low endotoxin for preclinical and clinical subunit, from a PEG/rMETase ratio of 30/1 in the syn-studies targeting the methionine dependence of human thetic reaction, had a molecular mass of approxi-cancer (12). and proteins, rMETase may be immunogenic in higher PEG-rMETase could deplete serum methionine levels animals, which may limit the utility of rMETase espe- Various approaches have been taken in attempts to Purification of rMETase solve the problem of antigenicity of polypeptides and Precolumn treatment. The bacterial pellet was disproteins. Coupling of polyethylene glycol (PEG) to pro-rupted with a cavitator-type homogenizer (Microfluiteins is one of the most effective approaches to reducing dics Corp., Newton, MA, model No. HC 8000). Heat protein antigenicity (17-23). Furthermore, PEG modi-treatment of the homogenate was carried out at 50ЊC fication improves the pharmacological properties of for 1 min. After centrifugation, the pH of the supernaproteins, usually extending plasma half-life and reduc-tant was adjusted to 7.2 by ultrafiltration (12). ing both antigenicity and immunogenicity, and often DEAE Sepharose FF (pH 7.2) (Pharmacia, Uppsala, increasing in vivo bioactivity (17-23). For example, Sweden). Total protein (40-80 g) was loaded on a polyethylene-glycol-conjugated recombinant human DEAE Sepharose FF column (100/30). rMETase was megakaryocyte growth and development factor, a polyeluted with a linear gradient of 40 to 200 mM potaspeptide related to thrombopoietin, is approximately 10 sium chloride in 10 mM potassium phosphate buffer times more potent in vivo than the unconjugated polypH 7.2. The fractions containing rMETase were identipeptide and is active in humans (18) .
fied by activity assay (12). L-asparaginase is used in the treatment of hematolog-DEAE Sepharose FF (pH 8.3) . After dialysis, the ical malignancies. Adverse reactions such as an allergic pH of the sample was adjusted to 8.3, and 4-5 g of reaction leading to anaphylactic shock have limited its total protein (2-5 mg/ml) was applied on the column clinical use (19). In addition, due to its rapid plasma (50/30) (12). rMETase was eluted with a linear gradient clearance, large doses and repeated administration are of 80 to 200 mM potassium chloride in 10 mM potasrequired to achieve clinical effects (19). Polyethylenesium phosphate buffer (pH 8.3). The fractions conglycol-conjugated L-asparaginase has reduced antigenictaining rMETase were identified by activity assay (12). ity and a very long half-life while maintaining high activity in hematological malignancies (19) .
Endotoxin removal by Acticlean Etox (Sterogen, ArcaWe report here that polyethylene glycol conjugation dia, CA). After dialysis in 0.15 M sodium chloride and of methioninase is feasible, results in readily purified 10 mM sodium phosphate buffer, pH 7.2, purified molecules, maintains the potency of the enzyme, ex-rMETase (10-20 mg protein/ml) was applied on an Actends its serum half-life, and maintains its tumor-spe-ticlean Etox column (25/60). rMETase was eluted with cific efficacy. elution buffer (0.12 M sodium chloride in 10 mM sodium phosphate, pH 7.2 ). The fractions containing rMETase were identified by activity assay (12).
MATERIALS AND METHODS

Materials
PEGylation of rMETase The N-hydroxysuccinimidyl ester of methoxypolyeth-PEG linkers. The M-SPA-PEG 5000 was used for ylene glycol propionic acid (M-SPA-PEG, MW 5000) rMETase PEGylation. was purchased from Shearwater Polymers Inc. (HuntsPEGylation reaction. PEG reagents were dissolved ville, AL). Other chemicals were purchased from Sigma in 20 mM sodium phosphate buffer (pH 8.3) at concen-(St. Louis, MO). Cell culture medium was purchased trations between 2 and 20 mM. The molar ratios of PEG from Fisher Scientific (Pittsburgh, PA).
to rMETase were varied from 10:1 to 60:1. For each condition, 0.3-0.5 g rMETase (15 mg/ml) was used.
Methods
PEGylation reactions were carried out in reaction buffer (20 mM sodium phosphate buffer, pH 8.3), at 20ЊC for Production of rMETase 30 to 60 min. The reactions were stopped with one-tenth High-expression clone of rMETase and fermentation volume stop buffer (1 M sodium phosphate buffer, pH conditions. The pAC-1 rMETase high-expression clone, 6.5) at 0ЊC (17). PEG-rMETase was then concentrated constructed in our laboratory, was used for the produc-by a Centriprep-30 (Amicon Inc., Beverly, MA). tion of rMETase. The fermentation procedure for host E. coli cells and the purification protocol for rMETase Purification of PEG-rMETases were as previously described (12). pAC-1 was constructed with the pT7-7 vector containing the T7 RNA Sephacryl S-300. Unreacted PEG was removed by size-exclusion chromatography Sephacryl S-300 HR polymerase promotor for high expression of the rMETase gene cloned from Pseudomonas putida as pre-column (HiPrep 26/60, Pharmacia), with a diameter of 26 nm and length of 60 cm (23). Ten milliliters of viously described (12). The host E. coli were grown in Terrific Broth in shaker flasks and harvested when the PEGylation products (15 mg/ml) were loaded on the column which was equilibrated and eluted with 0.15 OD 600 reached 20. The expression level of rMETase reached approximately 1 g/liter of fermentation broth M sodium chloride in 10 mM sodium phosphate (pH 7.4) at a flow rate of 1 ml/min. The fractions containing under these conditions (12).
FIG. 1.
Purification of PEG-rMETase. (a) Sephacryl S-300 HR chromatography. Unreacted M-SPA-PEG 5000 was removed by sizeexclusion chromatography using Sephacryl S-300 HR ( HiPrep 26/60, Pharmacia ). Ten milliliters of PEGylation reaction product were loaded on the column which was eluted with 0.15 M sodium chloride in 10 mM sodium phosphate buffer (pH 7.4) at a flow rate of 1 ml/ min. Five-milliliter fractions were collected. Peak 1 contained PEG-rMETase and rMETase. Peak 2 contained M-SPA-PEG 5000. Identify was confirmed by OD 280 , activity assay, and electrophoresis on SDS-PAGE using standards indicated under Materials and Methods. (b) DEAE Sepharose FF chromatography. Un-PEGylated rMETase was removed by DEAE Sepharose FF chromatography (XK 16/15, Pharmacia). Twenty milliliters of peak 1 from the Sephacryl S-300 HR chromatography were loaded on the column. PEG-rMETase (peak 1) was eluted with 50 mM sodium chloride in 10 mM sodium phosphate, pH 7.4, while the rMETase (peak 2) was eluted with 120 mM sodium chloride in 10 mM sodium phosphate pH 7.4. The flow rate was 3 ml/min. Identify was confirmed by activity assay and electrophoresis on SDS-PAGE using standards indicated under Materials and Methods.
PEG-rMETase and rMETase were eluted at approxiPotency activity assay. The assay was carried out in a 1-ml volume of 50 mM phosphate buffer pH 8.0, mately 150-250 ml and identified by activity assay.
containing 10 mM pyridoxal phosphate and 10 mM me-DEAE Sepharose FF. PEGylated rMETase was thionine for 10 min at 37ЊC with varying amounts of separated from un-PEGylated rMETase by anion-exenzyme. The a-ketobutyrate product of the enzyme rechange chromatography using a DEAE Sepharose FF action was detected with 3-methyl-2-benzothiazolinone column (XK 16/15, Pharmacia) with a diameter of 16 hydrazone measured at OD 335 . The specific activity was mm and length of 15 cm (12, 22). The column was equilibrated with equilibration buffer [50 mM sodium chloride in 10 mM sodium phosphate (pH 7.4)] and eluted with a 0-60% linear gradient of 300 mM sodium chloride in 10 mM sodium phosphate (pH 7.4) at a 3 ml/ min flow rate. The fractions containing PEG-rMETase were eluted with approximately 50-80 ml equilibration buffer and were indentified by activity assay and electrophoresis on SDS-PAGE.
Sterilization and stability of PEG-rMETase. The PEG-rMETases were sterilized by filtration with a 0.2 mM micrometer membrane filter. PEG-rMETase was stored at 080ЊC for 6 months without loss of activity.
Analysis of PEG-rMETase
Electrophoresis. PAGE was carried out in 7.5% polyacrylamide-precasted plates in 0.2 M Tris-glycine and aprotinin (MW 6.6 k) (12). 
Note. rMETase was PEGylated with M-SPA-PEG 5000 at the different molar ratios of PEG and rMETase under conditions described under Materials and Methods. The specific activity was measured and the relative activity to rMETase was calculated as described under Materials and Methods. The experiments were repeated twice and the standard deviations are given.
calculated as units per milligram protein, with 1 unit by acetonitrile (75 ml). Ten microliters of supernatant were mixed with 5 ml of OPA. After 1 min, 50 ml of 0.1 of enzyme defined as the amount that catalyzes the formation of 1 mmol of a-ketobutyrate per minute (12). M sodium acetate (pH 7.0 ) was added, and a 20 ml sample was loaded on a reversed-phase Supelcosil LCEndotoxin assay. 
(methanol). A gradient from 20-60% Matrix-Assisted Laser Desorption/Ionization Mass
was run at a flow rate of 1.5 ml/min. The eluate was Spectrometry read by a fluorescence spectrophotometer (Hitachi, Matrix-assisted laser desorption/ionization (MALDI) F1000) at 350-450 nm. The limit of detection was apmass spectrometry was performed with a PerSeptive proximately 0.1 mM methionine. Biosystems Voyager-Elite mass spectrometer with delayed extraction. Samples were irradiated with a nitrogen laser (Laser Science, Inc.) operated at 337 nM. The Organ Distribution of rMETase and PEG-rMETase in laser beam was attenuated by a variable attenuator Mice after iv Injection and focused on the sample target. Ions produced in the rMETase and PEG-rMETase (60 units) were injected ion source were accelerated with a deflection voltage of into the tail vein of three BALB/c nu/nu mice with sub-30,000 V. The ions were then differentiated according cutaneously growing human colon cancer HCT 15. to the m/z using a time-of-flight mass analyzer (23).
After 1 h, the mice were sacrificed, and the tumor, liver, kidney, spleen, intestine, heart, lung, muscle, and skin Serum Half-life of PEG-rMETase were collected and weighed. The tissues were thorIn vivo serum clearance rates for both rMETase and oughly washed before analysis such that any residual PEG-rMETase were analyzed in 8-week-old male Don-blood methioninase was eliminated. The tissues were ryu rats with body weights of 180-200 g. Purified PEG-then sonicated, and the PEG-rMETase or rMETase levrMETase or rMETase (180 units) was injected into the els were determined by activity assay. The levels of tail vein. Blood was collected at the following time PEG-rMETase or rMETase in tissues were calculated points : before injection, 5 min, 15 min, 30 min, 45 min, as units per milligram protein of tissue. 1 h, 2 h, 4 h, and 8 h after injection. Enzyme activity was measured as described above and the half-life of Growth Inhibitory Effect of PEG-rMETase on Human PEG-rMETase and that of rMETase were calculated.
Cancer Cells in Vitro Serum Methionine Measurement
Human normal and tumor cells were incubated in methionine-containing RPMI 1640 medium suppleSerum methionine measurement was performed by HPLC (Hitachi L-6200A Intelligent pump, Hitachi, mented with 10% fetal bovine serum with PEG-rMETase or rMETase (0.005-4 units/ml) for 72 h at 37ЊC/ Ltd, Tokyo, Japan) after derivitization of serum amino acids with a fluoraldehyde reagent, ophthaldialdehyde 5% CO 2 . After the 72-h incubation period, the cells were counted with a hemocytometer and relative (OPA) (16) . A methionine standard (Sigma) was derivitized by OPA. Serum samples (25 ml) were precipitated growth rates were calculated. at P/M ratios of 10-30 (Fig. 2) , which might be due to PEG molecules released from some subunits during denaturation with SDS and heating to 94ЊC.
Enzyme Activity of PEG-rMETase
The enzyme activity of PEG-rMETase depended on the P/M ratio. The PEG-rMETase synthesized at P/M ratios of 20 to 30 had activities of approximately 60-70% that of rMETase. At higher P/M ratios of 60 to 120, the resulting PEG-rMETase had activities of approximately 40-20% that of rMETase (Table 1) .
Extent of Derivitization of rMETase with PEG
MALDI mass spectrometry results confirmed that   FIG. 4 . Pharmacokinetics of PEG-rMETase. One hundred eighty rMETase (molecular mass 172 kda) is composed of four units of purified PEG-rMETase from the PEGylation reaction ratio identical subunits of MW 43 kda (Fig. 3a) . MALDI reof PEG/rMDETase 30/1 or purified rMETase was injected into the sults for PEG-rMETase indicated that PEG-rMETase tail vein of Donryu rats. The blood was collected at the following contained mainly four broad peaks, corresponding to time points: before injection, 5 min, 15 min, 30 min, 45 min, 1 h, 2 h, 4 h, and 8 h after injection. Serum enzyme activities were mea-molecular weights 52,661 { 5000 and 106,631 { 8000 sured as described under Materials and Methods.
for the monomer and dimer, respectively. These molecular weights are consistent with each subunit linked to two M-SPA-PEG 5000 molecules. The broadness of the signals is due to molecular heterogeneity of M-SPA-
RESULTS AND DISCUSSION
PEG 5000 (Fig. 3b) .
Purification of PEG-rMETase
After the conjugation reaction of rMETase and M-
Half-life of PEG-rMETase in Vivo SPA-PEG 5000, Sephacryl S-300 HR was used to remove the excess free PEG. The PEG-rMETase and
The t 1/2 in serum of PEG-rMETase after iv injection rMETase were eluted in the exclusion volume (Fig. 1a) . in rats was approximately 160 min compared to apFree M-SPA-PEG 5000 eluted in later fractions.
proximately 80 min of rMETase (Fig. 4) . The results The un-PEGylated rMETase was separated from demonstrated that the serum half-life of PEG-rMETase rMETase by DEAE Sepharose FF column chromatog-increased to approximately twice that of rMETase raphy. PEG-rMETase eluted early before the gradient when given by iv injection. was applied due to the reduced charge, while rMETase eluted after application of the gradient (Fig. 1b) . The results suggest that rMETase was efficiently conjugated with PEG. Identify was confirmed with electrophoresis on both SDS-PAGE and native-PAGE (Fig.  2 ). PEG-rMETase had a much larger molecular mass than rMETase, which is 172 kda on native-PAGE. The subunits of PEG-rMETase were also larger than the subunits of rMETase, which have a molecular mass of 43 kda.
Purity of PEG-rMETase
Electrophoretic analyses by SDS-PAGE demonstrated PEGylation of rMETase at PEG/rMETase (P/ M) ratios from 10-120 (Fig. 2) . The migration rates of PEG-rMETase molecules were much slower than those that the subunits of rMETase were all linked with PEG injected into the tail vein of Donryu rats. The blood was collected at at P/M ratios greater than 30. There was a slight band the time points indicated as described in Fig. 4 . Serum methionine levels were measured as described under Materials and Methods.
at 43 kda on SDS-PAGE of PEG-rMETase synthesized
FIG. 6.
Organ distribution of iv-administered PEGrMETase and rMETase in human tumor-bearing mice. Sixty units of rMETase or PEGrMETase were injected into the tail vein of three BALB/c nu/nu mice with subcutaneously growing human colon cancer HCT 15. After 1 h, the mice were sacrificed, and the tumor, liver, kidney, spleen, intestine, heart, lung, muscle, and skin were collected and weighed. The tissues were then sonicated, and the rMETase levels were determined by activity assay. The relative levels of rMETase were calculated as units per milligram protein of tissue.
Depletion of Methionine in the Serum
lowing decreasing order: blood, kidney, liver, spleen, heart, lung, tumor, intestine, and muscle (Fig. 6 ). SigThe depletion of methionine in rat serum by iv injecnificant PEG-rMETase levels accumulated in the tution of 180 units PEG-rMETase reached maximum mor. One hour after iv injection of 60 units of PEGdepletion from 50 to 0.1 mM within 5 min after the rMETase, levels were approximately 0.026 units/mg start of the infusion. Methionine depletion to approxiprotein in human colon tumor HCT 15 grown subcutamately 0.1 mM was maintained for at least 8 h after a neously in nude mice compared to 0.017 units/mg prosingle iv injection of PEG-rMETase, which was much tein for rMETase. These results demonstrated that more effective than rMETase, which could deplete me-PEG-rMETase could accumulate in the tumor at least thionine after one injection but could only maintain as well as rMETase. depletion at 0.1 mM for 2 h (Fig. 5) . These levels of depleted methionine correspond to therapeutic levels for cancer cells in vitro (M. Xu., Y. Tan, and R. M. Hoff-Growth Inhibitory Effect of PEG-rMETase on Human man, et al., unpublished data).
Cancer and Normal Cells in Vitro
Organ Distribution of PEG-rMETase in Mice after iv Human lung cancer cell line H460 and human kidney Administration cancer cell line SN12C had PEG-rMETase IC 50 s (concentrations which resulted in 50% inhibition of cell After iv administration to nude mice, the tissue distribution of PEG-rMETase was found to be in the fol-growth) of 0.04 and 0.06 units/ml, respectively, in vitro. Note. Human cells were incubated in methionine-containing RPMI 1640 medium supplemented with 10% FBS with rMETase or PEGrMETase (0.125-4 units/ml) for 72 h at 37ЊC/5% CO 2 . The IC 50 was calculated as the concentration of rMETase which inhibited 50% cell growth. The experiments were repeated twice and the standard deviations are given. The differences in the IC 50 of tumor cell lines compared with normal cell strains were significant (P õ 0.01).
9. Lishko, V. K., Lishko, O. V., and Hoffman, R. M. (1993) The prepIn striking contrast, normal human lung bronchial cell aration of endotoxin-free L-methionine-a-deamino-mercaptostrain NHBE and normal human kidney cells HRCE methane-lyase (L-methioninase) from Pseudomonas putida. Prohad PEG-rMETase IC 50 s of 1.5 and 0.8, respectively, half-life of PEG-rMETase extended the time of serum 12. Tan, Y., Xu, M., Tan, X. Z., Tan, X., Wang., X., Saikawa, S., methionine depletion in the mice which should give Nagahama, T., Sun, X., Lenz, M., and Hoffman, R. M. (1997) enhanced in vivo anti-tumor efficacy and decrease the Overexpression and large-scale production of recombinant L-methionine-a-deamino-g-mercaptomethane-lyase for novel antitherapeutic dose of enzyme needed. In a study of the cancer therapy. Protein Expression Purif. 9, 233-245.
active systemic anaphylaxis assay (ASA) of PEG-MET-13. Inoue, H., Inagaki, K., Sugimoto, M., Esaki, N., Soda, K., and ase in Guinea pigs, the results demonstrated that 
